Schaeffer's Top Stock Picks for '25

Bulls Blast Viking Therapeutics Stock on Trial Data

Shares have reversed course from a fresh high, however

Digital Content Manager
May 16, 2023 at 10:24 AM
facebook X logo linkedin


Viking Therapeutics Inc (NASDAQ:VKTX) today announced a win for its experimental drug to treat patients with a type of fatty liver disease called non-alcoholic steatohepatitis (NASH). The treatment met the main goal of its mid-stage trial, which was to statistically lower liver fat content.

Despite surging to a four-year high of $23.61 earlier, shares were last seen down 1.7% to trade at $21.61. The security still boasts support from the 20-day moving average, though, which has been in place since March. VKTX also sports a 831.8% year-over-year lead, with 132% added in 2023.

The security looks ripe for a short squeeze, too. The 11.59 million shares sold short account for 12.3% of Viking Therapeutics stock's available float, or roughly three days' worth of pent-up buying power.

The equity's usually quiet options pits are bursting with activity today. In fact, 9,640 calls  have already crossed the tape, or nine times the intraday average volume, compared to 976 puts. The most popular contract is the August 10 call, followed by the November 10 call.

 
 

You have the chance to join one of Bernie's most exclusive programs, complete access at HUGE savings!

As we prepare for a new administration to take the reins in Washington, the near-term market landscape is rife with uncertainty.

The Federal Reserve has already hinted at the turbulence ahead, lowering its interest rate outlook for 2025.

Meanwhile, breakthroughs in artificial intelligence (AI), quantum computing, and other transformative sectors have unlocked incredible profit potential.

But these opportunities are fleeting, and timing is everything. That's where Quick-Hit Trader comes in.

Quick-Hit Trader is designed for precision and speed, getting you in and out of the market in a flash. While other investors scramble to navigate volatile conditions, you'll have access to expertly curated trades that leverage these rapid shifts to deliver explosive profits in short order.

This is your chance to capitalize on the fast-moving market like never before. Are you ready to make your move?